10 Best Penny Stocks Under $1 to Buy for Q1 2025

Penny stocks are high risk, high reward companies. These can be the best place to look for the next big thing. Here are our top five penny stocks under $1 to buy this year.
Written by
Updated on Jul 4, 2024
Reading time 12 minutes

Our experts have analysed the market to find their 10 best penny stocks below $1. Keep reading to see which companies make up the best stocks we’re most excited by right now, along with a summary of each one.

What are the 10 top penny stocks under $1 to buy?

Copy link to section

These are the best penny stocks for the year ahead, according to our experts. You can find their latest share price by clicking on one of the links in the table, or scroll down to learn more about why they made the list.

#Stock symbolCompany nameLearn more
1GOEVCanooLearn more >
2NOKNokia OyjLearn more >
3SHIPSeanergy Maritime Holdings Corp.Learn more >
4RKDAArcadia Biosciences Inc.Learn more >
5GTEGran Tierra Energy Inc.Learn more >
6GPLGreat Panther MiningLearn more >
7AITXArtificial Intelligence TechnologyLearn more >
8BIOLBiolaseLearn more >
9TTOOT2 BiosystemsLearn more >
10ASRTAssertio TherapeuticsLearn more >
List chosen by our team of analysts, updated January 2025.

10 best penny stocks to buy, reviewed

Copy link to section

1. Canoo(NASDAQ: GOEV)

Copy link to section
  • Market Cap: $144 million
  • 1-year Performance: -83%
  • 5-year Performance: -100%

Canoo is a small electric vehicle company that is building vehicles meant for corporations and government agencies. Its stock has crashed from $106 in 2021 to less than $1 today because of its perpetual cash burn and the ongoing woes in the EV sector. Its balance sheet is having difficulties since it has less than $8 million in cash and is burning tens of millions of dollars each quarter.

Still, Canoo could become a major player in the EV sector because of its substantial orders. It has over $3 billion in orders, with $750 million being confirmed. These orders are from companies like Walmart and Zeeba. It has also received orders from NASA and USPS.

2. Nokia Oyj (NYSE: NOK)

Copy link to section
  • Market Cap: $21.9 billion.
  • 1-Year Performance: 1.95%
  • 5-Year Performance: -15%

Nokia is a Finnish telecoms company that makes computer hardware and network equipment. Best known as one of the biggest early providers of mobile phones, it now focuses almost exclusively on infrastructure and hardware instead.

The glory days at the cutting edge of mobile technology are gone, and Nokia’s share price is well off its peak. The last few years have been a time of transition, as it’s focused instead on producing network hardware and developing 5G infrastructure, a process that hasn’t been entirely successful.

That transition – and its lingering popularity with people who grew up using its phones – is why Nokia is second here. It has a substantial 15% market share of global telecoms equipment, new leadership, and 5G represents an opportunity to catapult it back to relevance.

3. Seanergy Maritime Holdings Corp. (NASDAQ: SHIP)

Copy link to section
  • Market Cap: $253 million.
  • 1-Year Performance: 187%
  • 5-Year Performance: -90%

Seanergy Maritime Holdings is a transportation company that owns a fleet of cargo ships. These are big ships, often used to move raw materials like coal around the world.

Shipping stocks tend to be particularly volatile, so you need to stay on top of the news cycle if you are going to invest. They’re also cyclical, tending to grow when global trade is booming and fall when economies start to stagnate. Institutional investors have drifted away from shipping, which is why stocks like this are trading so cheaply.

The reason SHIP is third on this list is it’s trading below the value of its assets – a fleet of 14 massive cargo ships. It’s also been able to improve its fundamental business model in recent times, setting it up for a potential rebound.

4. Arcadia Biosciences Inc. (NASDAQ: RKDA)

Copy link to section
  • Market Cap: $3.96 million.
  • 1-Year Performance: -39%
  • 5-Year Performance: -99%

Arcadia is an ‘agriculture biotech’ company that specialises in adapting crops to improve their nutritional and health benefits. It’s particularly focused on wheat, soybean, and hemp.

Recent times have been tough for Arcadia, thanks to a difficult financial situation and a share price that has fallen from well over $100 in 2015 to reside in the penny stock zone, below $5, since 2019. 

The potential upside is its focus on healthy food and adapting common crops to offer farmers more environmentally-friendly solutions. Arcadia could be primed to benefit from a world that’s becoming more concerned with finding climate conscious solutions to the difficult problem of feeding a growing population. 

5. Gran Tierra Energy Inc. (NYSEAMERICAN: GTE)

Copy link to section
  • Market Cap: $278 million
  • 1-Year Performance: 60%
  • 5-Year Performance: -54%

Gran Tierra Energy is an energy company that’s involved in oil and gas exploration. It operates in South America, particularly Colombia and Ecuador, to discover new sources of oil and gas and then develop and produce the fuel.

Like many of the companies on this list, it has fallen on hard times. Gran Tierra shares peaked close to $10 in 2011, but had collapsed to just $0.30 in the aftermath of the March 2020 coronavirus crash, when oil prices briefly fell below zero. It has now jumped to over $8, helped by higher oil prices.

Much of GTE’s business plan relies on oil prices being around $50, and in discovering new sources of oil in Ecuador. It has experience in exploring and extracting oil in remote locations and is predicting a steep increase in revenues in the months and years to come.

6. Great Panther Mining (NYSEAMERICAN: GPL)

Copy link to section
  • Market Cap: $471k
  • 1-Year Performance: 89%
  • 5-Year Performance: -99%

Great Panther Mining is a Canadian company that mines precious metals like gold and silver. First founded in 1965, it has undergone a few transformations since then and now trades on both the Toronto Stock Exchange and the NYSE American.

The changes in the company over the past half century have taken it from an Emerald mining company that focused on exploration in Zimbabwe, to a metals miner with operations in Mexico and South America. Its stock has never been very expensive and has been stuck around the £1 mark for many years.

The reason for buying any mining or exploration company is the potential for it to discover lucrative new sites. Great Panther Mining is exploring a number of possible opportunities and if it is able to find some quality ore in these places then the stock might be able to reverse its long term trend.

7. Artificial Intelligence Technology (OTC: AITX)

Copy link to section
  • Market Cap: $66 million
  • 1-Year Performance: -30%
  • 5-Year Performance: -99%

Artificial Intelligence Technology is one of the most actively traded penny stock in Wall Street. The company has a market cap of over $72 million and regularly has daily trading volume of over 5 million shares.

AITX manufactures robots that are used in many industries like manufacturing and security. It is seeing strong revenue and annual recurring growth rate, which explains why the stock has risen by over 150% in the past three months.

However, the main challenge with the company is that it lavishes its CEO with substantial remuneration even when the stock is not doing well. The company does not have a good balance sheet, which could see it sell shares to raise money.

8. Biolase (NASDAQ: BIOL)

Copy link to section
  • Market Cap: $5.1 million.
  • 1-Year Performance: -98%
  • 5-Year Performance: -100%

Biolase is an American company that is the global leader in pioneering dental lasers. This technology lets dentists perform procedures without needing invasive drills, making the process much easier and more comfortable for the patients.

The company has been very badly affected by COVID-19, which is why its stock now trades at such a low price. Not only did lockdowns affect dental clinics themselves, but it meant salespeople couldn’t visit them and impacted international deliveries. Biolase’s 2020 results were even worse than the previous two years, and meant it has now reported losses for three years in a row.

The bullish case for Biolase is that the market might have overreacted to a one-off event and it can rebound after the pandemic eases. It has an innovative product and lots more (40+) laser systems in development. There might be a clearer route to profitability if it can get through its short term troubles.

9. T2 Biosystems (NASDAQ: TTOO)

Copy link to section
  • Market Cap: $79 million
  • 1-Year Performance: -54%
  • 5-Year Performance: -99%

T2 Biosystems is a biotech company whose technology is used to detect early signs of diseases like sepsis and Lyme disease. It can return blood test results in a few hours, compared to the days it would normally take, and identify bacteria earlier than has been possible up to now.

The reason T2 is available so cheap is because it has had some significant financial difficulties over the past couple of years. It pours a lot of money into developing new technology and regularly posts serious annual losses, to the extent that it has been close to running out of money. That has driven its share price down from nearly $10 to below $1.

Its ability to reverse the trend relies on having its diagnostic tests approved by the medical authorities, which is a process that’s difficult to predict. However, biotechs often only need a single, big name success to prove the technology works. Investing in cheap biotechs with little money is risky, without question, but there is the potential for them to rise dramatically in price if they capture the public imagination.

10. Assertio Therapeutics (NASDAQ: ASRT)

Copy link to section
  • Market Cap: $95 million
  • 1-Year Performance: -84%
  • 5-Year Performance: -91%

Assertio is a pharmaceutical company that develops treatments for the central nervous system and pain medication. It has fallen on hard times of late, after the patent protection for some of its successful drugs ran out, which is when other companies can come in and produce cheaper alternatives.

Since 2016, Assertio stock has lost 99% of its value. That led to it having to perform some financial gymnastics to stay afloat. If a stock falls below $1 for 30 days they can be removed from the NASDAQ exchange, so Assertio performed a reverse stock split (reducing the overall number so that each one is worth more). It worked for a while but the stock is back below $1 again at the time of writing.

It’s not a sustainable long term strategy to live so close to the line, so there’s more risk with Assertio than others on the list. However, pharma companies only need to get approval for one or two new treatments to make big money. Assertio has achieved that before and if you invest, that’s what you’re banking on happening again.

Where to buy the best penny stocks

Copy link to section

To get any stock, you need to find yourself an online stockbroker. The platforms below are some of the best around. You can use any one of these to get penny stocks right now.

We found 4 online brokers for users based in

Plus500 review
4.5
Plus500
Min. Deposit $100
Fees From 2%
No. assets 2800+
Demo account Yes

Plus500 review

CFD service. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

This information is NOT relevant to EU residents who are to be serviced by EU subsidiaries of the Plus500 Group, such as Plus500CY Ltd, authorised by CySEC (Reg. 250/14). Different regulatory requirements apply in Europe such as leverage limitations and bonus restrictions.

Public.com review
4.4
Public
Min. Deposit $20
Fees 1-2%
No. assets 9000+
Demo account No

Public.com review

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Crypto trading on Public platforms is served by Public Crypto LLC and offered through APEX Crypto. Please ensure that you fully understand the risks involved before trading.
Best penny stocks under $1 to buy
Min. Deposit n/a
Fees -
No. assets n/a
Demo account -

What is a penny stock?

Copy link to section

Companies whose shares cost below $5 in the US or £1 in the UK. They also have market capitalisations – the total value of all their shares combined – of less than $300m or £100m, respectively. Penny stocks tend to come without much of a track record of making money or creating good products, so investing them is a high risk, high reward opportunity.

Are penny shares a good investment?

Copy link to section

They can be in moderation, if you thoroughly research a company before investing. You have to be prepared for the fact that not every penny stock you buy is going to succeed; many are cheap because they aren’t good companies or have been surpassed by their competitors.

At this price point, it can be more difficult to buy the stock in the first place as well. Companies that don’t trade on the major stock exchanges, like the NYSE, NASDAQ, or FTSE, might not be available through your broker. On top of that, it’s harder to find information about them online.

The ones that do succeed, however, have the potential to pay off in a big way. It’s possible to see 5x or 10x returns on your investment. For that reason, the best way to use them is to spread small amounts around a number of different companies to improve your chances.

If you do decide to trade penny stocks, it’s important to keep tabs on them so that you’re able to react to new developments. Just making it into the news can have an impact on the price of a penny stock, and they’re often more volatile than more mainstream companies. The latest news below is the best way to do this.

Methodology: How we choose the best penny stocks

Copy link to section

At Invezz, our mission is to empower our readers with the most accurate and reliable financial information. Our curated selection of the best stocks in specific industries is designed to provide investors with well-researched, expertly reviewed stock recommendations. Our team follows a rigorous process to ensure our readers receive high-quality, trustworthy stock selections.

  • Initial screening. Our team of experienced stock market analysts conducts an initial screening of stocks within the chosen industry. This involves analyzing a broad range of companies based on key financial metrics such as revenue growth, profitability, debt levels, and market capitalization.
  • Earnings reports and financial analysis. Analysts review the latest earnings reports of shortlisted companies. This includes a detailed assessment of financial statements, looking for consistent earnings growth, strong balance sheets, and positive cash flow trends. Special attention is given to year-over-year performance and quarterly results.
  • Sector analysis. A comprehensive sector analysis is conducted to understand the macroeconomic factors affecting the industry. This includes examining market trends, competitive landscape, regulatory changes, and technological advancements. Our analysts utilize industry reports, market research, and economic forecasts to gain a holistic view of the sector.
  • Analyst recommendations. We consider recommendations from reputable sources such as Barron’s and Zacks. These sources provide expert opinions and ratings on stocks, which serve as an additional layer of validation for our selections. Incorporating external analyst recommendations ensures that our curated stocks are backed by a consensus of expert views.
  • Internal review. After the initial selection by our analysts, the chosen stocks are reviewed by a sub-editor. The sub-editor ensures that the analysis is clear, concise, and adheres to Invezz’s editorial guidelines. This review process helps maintain the quality and readability of our content, making it accessible to a broad audience.
  • Quarterly updates. To ensure our stock recommendations remain relevant and up-to-date, we update the curated section quarterly. Each update cycle involves re-evaluating the stocks based on the latest financial reports, industry developments, and market conditions. This regular update process ensures that our recommendations reflect the most current information available.

Our approach combines expert analysis, comprehensive research, and regular updates to deliver reliable and insightful investment recommendations. Read more about our review process and editorial policy.


Sources & references

James Knight

James Knight

Editor of Education

  • Stock Market
  • Cryptocurrencies
  • Commodities
  • Investing
  • Sport
James is the Editor of Education for Invezz, where he covers topics from across the financial world, from the stock market, to cryptocurrency, to macroeconomic markets. His main focus is on improving financial literacy among casual investors. He has been with Invezz since the start of 2021 and has been...